Rabies vaccine, Hepatitis A vaccine or Meningococcal vaccine clinical trials

R21/Matrix-M in African Children Against Clinical Malaria

This study is testing a new malaria vaccine, R21/Matrix-M, in young children in Africa. It aims to see how well it protects them from malaria and if it's safe over a few years, including how many booster shots might be needed.